Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus

作者:Zhou, Haiyan*; Hu, Bailong; Huang, Niwen; Mo, Xiangang; Li, Wei; Zhang, Bei; Wei, Bo; Gao, Mingzhu; Wang, Yiming*; Liu, Xingde*; Liao, Joshua*
来源:Clinical Rheumatology, 2018, 37(9): 2405-2413.
DOI:10.1007/s10067-018-4124-0

摘要

To assess Teen subsets and levels of chemokines and cytokines in patients with SLE and determine their relationships between disease activity and organ involvement. Blood samples from SLE patients (n = 24) and healthy controls (n = 36) were analyzed. Frequency of divulging follicular help T cells (Tfh), central memory T cells (Tcm), effector memory T cells (Tcm), and naive T cell subsets was enumerated and their surface markers expression of inducible T cell co-stimulator (ICOS) and programmed death 1(PD-1) protein was examined by flow cytometry. The disease state in SLE patients was evaluated using the SLE Disease Activity Index (SLEDAI). Concentrations of autoantibodies. scrum C-reactive protein (CRP), the erythrocyte sedimentation rate (ESR), lgG, complement 3, complement 4, cytokines, and chemokines, such as IL-21, 1L-17A, and IL-1 beta, were measured. The frequencies of circulating Tfh and Tcm cell subsets were significantly Iowa than those in healthy controls. However, the percentages of circulating PD1(+)ICOS(+)Tfh, PD1(+)ICOS(+)Tcm, and PD1(+)ICOS(+)Tcm of PBMCs from SLE patients were higher than those in healthy controls. Furthermore, increased levels of serum IL-1 beta, IL-4, IL-6. MCP-1, IL-21, and IL-17A were detected in the patients with SLE compared to healthy controls. In addition, patients with immune thrombocytopenia displayed elevated proportions of serum IL-10, IL-17A, and 1L-1 beta. Aberrant T cell subsets and cytokines expression profile were observed in SLE patients. PD1(+)ICOS(+)Tcm cell subset was clearly influenced by disease activity and serum 1L-10, IL-17A, and IL-1 beta were significantly increased in patients with immune thrombocytopenia. Therefore. PD1(+)ICOS(+)Tcm cells might serve as an important tool for recognition and serum 1L-10, IL-17A, and IL-1 beta might be an effective monitor for SLE patients with immune thrombocytopenia.